Herbicidal properties of antimalarial drugs

被引:34
|
作者
Corral, Maxime G. [1 ,2 ]
Leroux, Julie [1 ,2 ]
Stubbs, Keith A. [1 ]
Mylne, Joshua S. [1 ,2 ]
机构
[1] Univ Western Australia, Sch Mol Sci, 35 Stirling Highway, Perth, WA 6009, Australia
[2] ARC Ctr Excellence Plant Energy Biol, 35 Stirling Highway, Perth, WA 6009, Australia
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
基金
澳大利亚研究理事会;
关键词
PLASMODIUM-FALCIPARUM MALARIA; NATURAL-WATERS; PARASITE; RESISTANCE; TARGET; ARABIDOPSIS; APICOMPLEXAN; TRIFLURALIN; INHIBITORS; APICOPLAST;
D O I
10.1038/srep45871
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The evolutionary relationship between plants and the malarial parasite Plasmodium falciparum is well established and underscored by the P. falciparum apicoplast, an essential chloroplast-like organelle. As a result of this relationship, studies have demonstrated that herbicides active against plants are also active against P. falciparum and thus could act as antimalarial drug leads. Here we show the converse is also true; many antimalarial compounds developed for human use are highly herbicidal. We found that human antimalarial drugs (e.g. sulfadiazine, sulfadoxine, pyrimethamine, cycloguanil) were lethal to the model plant Arabidopsis thaliana at similar concentrations to market herbicides glufosinate and glyphosate. Furthermore, the physicochemical properties of these herbicidal antimalarial compounds were similar to commercially used herbicides. The implications of this finding that many antimalarial compounds are herbicidal proffers two novel applications: (i) using the genetically tractable A. thaliana to reveal mode-of-action for understudied antimalarial drugs, and (ii) co-opting antimalarial compounds as a new source for much needed herbicide lead molecules.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] OCULAR INVOLVEMENT WITH ANTIMALARIAL DRUGS
    LONG, AP
    MADOW, BP
    DONALDY, WJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1963, 269 (23): : 1265 - &
  • [42] The safety of antimalarial drugs in pregnancy
    PhillipsHoward, PA
    Wood, D
    DRUG SAFETY, 1996, 14 (03) : 131 - 145
  • [43] Cardiotoxicity of antimalarial drugs.
    Touze, JE
    Heno, P
    Fourcade, L
    Deharo, JC
    Mafart, B
    Lemaitre, X
    MEDECINE ET MALADIES INFECTIEUSES, 1999, 29 : 316S - 325S
  • [44] A global subsidy for antimalarial drugs
    Gelband, Hellen
    Seiter, Andreas
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (06): : 219 - 221
  • [45] TOXIDERMIA WITH ANTIMALARIAL-DRUGS
    GILLET, P
    GILLETTERVER, MN
    BANNWARTH, B
    TRECHOT, P
    PERE, P
    NETTER, P
    GAUCHER, A
    THERAPIE, 1991, 46 (05): : 391 - 391
  • [46] ANTIMALARIAL-DRUGS - AN UPDATE
    WARHURST, DC
    DRUGS, 1987, 33 (01) : 50 - 65
  • [47] OCULAR REACTIONS TO ANTIMALARIAL DRUGS
    REBELLO, DJ
    ARCHIVES OF DERMATOLOGY, 1961, 83 (05) : 785 - &
  • [48] Antimalarial drugs - Here and on the horizon
    Hampton, Tracy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (20): : 2185 - 2186
  • [49] TOXICITY OF ANTIMALARIAL-DRUGS
    PETO, TEA
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1989, 82 : 30 - 33
  • [50] SOME SPECIFIC ANTIMALARIAL DRUGS
    CLOUGH, PW
    ANNALS OF INTERNAL MEDICINE, 1948, 29 (04) : 746 - 751